Articles · HRT
Bioidentical Hormones Decoded
FDA-approved bioidentical HRT exists. Compounded versions add cost, not benefit.
Sourced from peer-reviewed research and clinical guidelines, cited at the end of this article. How we write about your body.
“Bioidentical hormones” causes constant confusion, because the term means different things to different people and its use in marketing rarely matches its meaning in chemistry.
If you have looked into menopause treatment, you have probably seen the phrase used by compounding pharmacies, wellness clinics, or practitioners who present it as a natural alternative to standard HRT. The suggestion is that bioidentical hormones are safer and more effective than what doctors usually prescribe. The evidence does not support that, and seeing why means starting with what the word actually means.
What Bioidentical Actually Means
Bioidentical means the hormone molecule is exactly the same as the one your body makes. By that definition, 17-beta-estradiol is bioidentical: it is the same estrogen your ovaries made. Micronised progesterone is also bioidentical, chemically identical to human progesterone in every way.
Both are available as FDA-approved, regulated products. 17-beta-estradiol is the estrogen in the standard patches, gels, sprays, and many tablets used in conventional HRT. Micronised progesterone is the active ingredient in Utrogestan and Prometrium.
Conjugated equine estrogen (used in the original Women’s Health Initiative trial as Premarin) comes from horse urine and is not bioidentical. Synthetic progestogens like medroxyprogesterone acetate and norethisterone are not bioidentical either. To be clear: bioidentical does not mean compounded, and conventional does not mean non-bioidentical. These are separate ideas and should not be mixed up.
The Compounding Confusion
The term “bioidentical hormones” has largely been taken over by compounding pharmacies to describe their custom-mixed hormone preparations. These are sold as better than conventional HRT, with marketing built on words like natural, individualised, and safer.
Compounded bioidentical hormone therapy (cBHT) means hormones mixed by a compounding pharmacy to a specific formula, usually based on saliva or blood hormone tests. The products often combine several hormones, such as estradiol, progesterone, testosterone, and DHEA, in one cream or lozenge.
The American College of Obstetricians and Gynecologists (ACOG) published a 2023 Clinical Consensus statement that is blunt on this: FDA-approved menopausal hormone therapies should be recommended over compounded bioidentical menopausal hormone therapy, and patients should be told the evidence for the safety and effectiveness of cBHT is lacking.[1]
The FDA says the same: there is no evidence that compounded bioidentical hormones are safe and effective, or safer or more effective than FDA-approved hormone therapy.[2]
Problems With Compounded Preparations
Unpredictable dosing. Compounded products are not tested for consistency. A cream from a compounding pharmacy may contain much more or much less hormone than the label says, and the daily amount absorbed can vary with the application site, skin condition, and how stable the mixture is. The FDA’s adverse event system contains cases of serious harm from excessive doses of estrogen, progesterone, and testosterone, specifically from compounded pellets.[1]
No long-term safety data. The trial evidence for HRT comes almost entirely from FDA-approved products tested in large studies. Those trials established both the benefits and the risks of HRT at set doses. Compounded preparations have not been tested the same way. Borrowing the safety data from regulated products and applying it to compounded ones is not valid.
Hormone pellets carry specific risks. Pellets placed under the skin release a fixed amount of hormone that cannot be adjusted or removed once in. Because they release hormone continuously and unpredictably, they often push levels above the normal range. Women on pellets frequently have testosterone and estradiol far above the premenopausal range, which brings its own risks and effects (acne, voice changes) that most women seeking HRT do not want.
Saliva testing does not reliably guide dosing. Many cBHT protocols test saliva to set hormone levels and personalise the mix. Saliva hormone testing is not validated for dosing decisions. Saliva estradiol does not track serum levels reliably, and results shift with collection time and technique.[3] NAMS and ACOG do not recommend saliva testing to guide HRT dosing.
Choosing Bioidentical HRT
If you want bioidentical hormones, and there are fair reasons to prefer them (including the observed link between synthetic progestogens and higher breast cancer risk, which depends on dose and duration and is still debated across progestogen types[4]), FDA-approved bioidentical products give you exactly that, with quality control, safety monitoring, and a real evidence base.
The standard prescription is transdermal 17-beta-estradiol (patch, gel, or spray) plus micronised progesterone (Utrogestan or Prometrium) for women who still have a womb. This is what NICE, the British Menopause Society, and other current guidelines recommend as the preferred HRT for most women.[4] It is also bioidentical by any technical definition. If you are unsure which form is right for you, a qualified menopause specialist, not a compounding clinic, is the place to start.
The problems above (unpredictable dosing, no long-term trial data, and the specific hazards of pellets) narrow the sensible use of cBHT to a small set of situations: a woman who cannot tolerate any approved formulation, needs a dose not sold commercially, or is allergic to an ingredient in approved products. For most women seeking menopause treatment, compounding adds cost and uncertainty without adding benefit.
References
[1] American College of Obstetricians and Gynecologists. (2023). Compounded Bioidentical Menopausal Hormone Therapy: ACOG Clinical Consensus No. 6. https://pubmed.ncbi.nlm.nih.gov/37856860/
[2] US Food and Drug Administration. Menopause and hormones: common questions. https://www.fda.gov/media/130242/download
[3] Stanczyk, F. Z., Jurow, J., Hsing, A. W. (2010). Limitations of direct immunoassays for measuring circulating estradiol levels in postmenopausal women and their implications for epidemiologic studies. Cancer Epidemiology, Biomarkers & Prevention, 19(4), 903-906. Cited in: Bioidentical hormone therapy review. https://pmc.ncbi.nlm.nih.gov/articles/PMC3127562/
[4] NICE Guideline NG23. (2023). Menopause: Diagnosis and Management. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/ng23
Teala surfaces health patterns to help you and your doctor make informed decisions. It does not diagnose conditions or replace medical advice. Always consult a qualified healthcare professional about your symptoms and treatment.